OBJECTIVE: To estimate the frequency of mismatch repair deficiencies associated with hereditary nonpolyposis colorectal cancer, or Lynch syndrome, in women less than age 50 with endometrial cancer. METHODS: Consecutive patients less than age 50 diagnosed with endometrial adenocarcinoma were identified. Available pathologic specimens were freshly sliced, and protein expression for MLH1, MSH2, MSH6, and PMS2 was evaluated by immunohistochemistry. Slides were scored on a semiquantitative method with complete absence of any of the four proteins suggesting a deficiency. All results were confirmed by microsatellite instability testing. RESULTS: Sixty-one pathology specimens were analyzed. Twenty-one (34%) of the tumors had absence of staining of at least one of the four mismatch repair proteins determined by immunohistochemistry and confirmed by microsatellite instability testing. Obese patients were less likely than nonobese patients to have a mismatch repair deficiency (21% versus 59%, respectively). Non-obese patients had a relative risk for a mismatch repair deficiency of 5.5 (95% confidence interval 1.6-19.1; P=.01). CONCLUSION: Many women diagnosed with endometrial cancer before age 50 will have a mismatch repair deficiency discovered by immunohistochemistry and microsatellite instability testing. A number of young women diagnosed with endometrial cancer will require further genetic testing for mismatch repair mutations. LEVEL OF EVIDENCE: III.
OBJECTIVE: To estimate the frequency of mismatch repair deficiencies associated with hereditary nonpolyposis colorectal cancer, or Lynch syndrome, in women less than age 50 with endometrial cancer. METHODS: Consecutive patients less than age 50 diagnosed with endometrial adenocarcinoma were identified. Available pathologic specimens were freshly sliced, and protein expression for MLH1, MSH2, MSH6, and PMS2 was evaluated by immunohistochemistry. Slides were scored on a semiquantitative method with complete absence of any of the four proteins suggesting a deficiency. All results were confirmed by microsatellite instability testing. RESULTS: Sixty-one pathology specimens were analyzed. Twenty-one (34%) of the tumors had absence of staining of at least one of the four mismatch repair proteins determined by immunohistochemistry and confirmed by microsatellite instability testing. Obesepatients were less likely than nonobese patients to have a mismatch repair deficiency (21% versus 59%, respectively). Non-obesepatients had a relative risk for a mismatch repair deficiency of 5.5 (95% confidence interval 1.6-19.1; P=.01). CONCLUSION: Many women diagnosed with endometrial cancer before age 50 will have a mismatch repair deficiency discovered by immunohistochemistry and microsatellite instability testing. A number of young women diagnosed with endometrial cancer will require further genetic testing for mismatch repair mutations. LEVEL OF EVIDENCE: III.
Authors: U Manne; R B Myers; C Moron; R B Poczatek; S Dillard; H Weiss; D Brown; S Srivastava; W E Grizzle Journal: Int J Cancer Date: 1997-06-20 Impact factor: 7.396
Authors: Melissa C Southey; Mark A Jenkins; Leeanne Mead; Jonathan Whitty; Melanie Trivett; Andrea A Tesoriero; Letitia D Smith; Kim Jennings; Garry Grubb; Simon G Royce; Michael D Walsh; Melissa A Barker; Joanne P Young; Jeremy R Jass; D James B St John; Finlay A Macrae; Graham G Giles; John L Hopper Journal: J Clin Oncol Date: 2005-08-22 Impact factor: 44.544
Authors: Karen H Lu; Mai Dinh; Wendy Kohlmann; Patrice Watson; Jane Green; Sapna Syngal; Prathap Bandipalliam; Lee-May Chen; Brian Allen; Peggy Conrad; Jonathan Terdiman; Charlotte Sun; Molly Daniels; Thomas Burke; David M Gershenson; Henry Lynch; Patrick Lynch; Russell R Broaddus Journal: Obstet Gynecol Date: 2005-03 Impact factor: 7.661
Authors: Maran J W Berends; Ying Wu; Rolf H Sijmons; Rob G J Mensink; Tineke van der Sluis; Jannet M Hordijk-Hos; Elisabeth G E de Vries; Harry Hollema; Arend Karrenbeld; Charles H C M Buys; Ate G J van der Zee; Robert M W Hofstra; Jan H Kleibeuker Journal: Am J Hum Genet Date: 2002-01 Impact factor: 11.025
Authors: Maran J W Berends; Ying Wu; Rolf H Sijmons; Tineke van der Sluis; Wietske Boersmavan Ek; Marjolijn J L Ligtenberg; Neeltje J W Arts; Klaske A ten Hoor; Jan H Kleibeuker; Elisabeth G E de Vries; Marian J E Mourits; Harry Hollema; Charles H C M Buys; Robert M W Hofstra; Ate G J van der Zee Journal: J Clin Oncol Date: 2003-12-01 Impact factor: 44.544
Authors: Amy S Joehlin-Price; Carmen M Perrino; Julie Stephens; Floor J Backes; Paul J Goodfellow; David E Cohn; Adrian A Suarez Journal: Gynecol Oncol Date: 2014-01-17 Impact factor: 5.482
Authors: Penelope M Webb; Amanda B Spurdle; Christina M Nagle; Tracy A O'Mara; Yen Tan; Daniel D Buchanan; Andreas Obermair; Penny Blomfield; Michael A Quinn Journal: J Gynecol Oncol Date: 2018-02-23 Impact factor: 4.401